Damora Therapeutics DMRA
NASDAQ DMRA
$20.16 -0.07 (-0.35%)
As of: Oct 2, 2026 · 2:34 PM EDT

Damora Therapeutics (DMRA) Depreciation & Amortization (CF) (2021 - 2026)

Updated

Damora Therapeutics (DMRA) posted Depreciation & Amortization (CF) of $6,000 for Q2 2026, unchanged from $6,000 a year earlier and up 20.0% from the prior quarter.

Analysis

Damora Therapeutics (DMRA) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Damora Therapeutics was $23,000, up 4.5% year-over-year; for FY2025, it came in at $22,000, up 4.8% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a four-year compound annual growth rate of 2.4% (FY2021 to FY2025).
  • In prior years, Damora Therapeutics' Depreciation & Amortization (CF) was $21,000 in FY2024 (-93.0%), $300,000 in FY2023 (+614.3%), $42,000 in FY2022 (+110.0%) and $20,000 in FY2021.
  • Quarterly Depreciation & Amortization (CF) has run from a low of $5,000 in Q1 2024 to a high of $211,000 in Q3 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average decline of 18.5%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2022, with growth of 300.0%; the weakest was Q3 2024, with a decline of 97.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $5,000 (Q1 2026), $6,000 (Q4 2025) and $6,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Damora Therapeutics 1.31 Bn -24.93 Mn - 6,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,000.00
Mar 31, 2026 5,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 6,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 54,000.00
Sep 30, 2023 211,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 18,000.00
Dec 31, 2022 21,000.00
Sep 30, 2022 6,000.00
Jun 30, 2022 7,000.00
Mar 31, 2022 8,000.00
Dec 31, 2021 7,000.00
Sep 30, 2021 8,000.00
API Access

Damora Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DMRA&period=max&api_key=YOUR_API_KEY